The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-N-((S)-3-amino-1-cyano-3-oxopropyl)-1-((4'-tert-butyl-[1,1'-biphenyl]-4-yl)sulfonyl)pyrrolidine-2-carboxamide ID: ALA3741594
PubChem CID: 127037715
Max Phase: Preclinical
Molecular Formula: C25H30N4O4S
Molecular Weight: 482.61
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)c1ccc(-c2ccc(S(=O)(=O)N3CCC[C@H]3C(=O)N[C@H](C#N)CC(N)=O)cc2)cc1
Standard InChI: InChI=1S/C25H30N4O4S/c1-25(2,3)19-10-6-17(7-11-19)18-8-12-21(13-9-18)34(32,33)29-14-4-5-22(29)24(31)28-20(16-26)15-23(27)30/h6-13,20,22H,4-5,14-15H2,1-3H3,(H2,27,30)(H,28,31)/t20-,22-/m0/s1
Standard InChI Key: ZWNFXBJAGVYQIA-UNMCSNQZSA-N
Molfile:
RDKit 2D
34 36 0 0 0 0 0 0 0 0999 V2000
2.5984 -2.7004 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5988 -1.5004 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.6377 -2.1009 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5052 1.0408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2543 -0.2587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2499 -1.3728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8990 -0.7508 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0377 0.7299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5461 -2.8414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4210 -3.8346 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6836 -3.2237 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7177 -5.3058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1403 -5.7840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5925 -6.2991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8892 -7.7703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0266 -8.1526 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9896 -8.5644 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2777 -6.1664 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5987 1.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6012 3.0004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1969 1.4963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8967 0.7484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1993 2.9963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9015 3.7484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5002 3.7446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5389 3.1436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5018 4.9446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5401 4.3435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
6 5 1 0
6 7 1 0
7 8 1 0
8 4 1 0
6 9 1 1
9 10 1 0
9 11 2 0
10 12 1 0
12 13 1 0
12 14 1 6
14 15 1 0
15 16 1 0
15 17 2 0
13 18 3 0
7 2 1 0
2 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
25 26 2 0
26 30 1 0
29 27 1 0
27 28 2 0
28 25 1 0
22 25 1 0
29 30 2 0
29 31 1 0
31 32 1 0
31 33 1 0
31 34 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 482.61Molecular Weight (Monoisotopic): 482.1988AlogP: 2.69#Rotatable Bonds: 7Polar Surface Area: 133.36Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.22CX Basic pKa: ┄CX LogP: 2.39CX LogD: 2.39Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.63Np Likeness Score: -1.31
References 1. Ness KA, Eddie SL, Higgins CA, Templeman A, D'Costa Z, Gaddale KK, Bouzzaoui S, Jordan L, Janssen D, Harrison T, Burkamp F, Young A, Burden R, Scott CJ, Mullan PB, Williams R.. (2015) Development of a potent and selective cell penetrant Legumain inhibitor., 25 (23): [PMID:26522952 ] [10.1016/j.bmcl.2015.10.001 ] 2. Eddie SL, Gregson A, Graham E, Burton S, Harrison T, Burden R, Scott CJ, Mullan PB, Williams R.. (2019) Identification and SAR exploration of a novel series of Legumain inhibitors., 29 (12): [PMID:31005445 ] [10.1016/j.bmcl.2019.03.019 ]